Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.

A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res. 2013 Aug 01; 73(15):4810-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.